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Background: The prevalence of type 2 diabetes is rising internationally. Patients with diabetes have a higher risk of
cardiovascular events accounting for substantial premature morbidity and mortality, and health care expenditure. Given
healthcare workforce limitations, there is a need to improve interventions that promote positive self-management
behaviours that enable patients to manage their chronic conditions effectively, across different cultural contexts.
Previous studies have evaluated the feasibility of including telephone and Short Message Service (SMS) follow up in
chronic disease self-management programs, but only for single diseases or in one specific population. Therefore, the
aim of this study is to evaluate the feasibility and short-term efficacy of incorporating telephone and text messaging to
support the care of patients with diabetes and cardiac disease, in Australia and in Taiwan.
Methods/design: A randomised controlled trial design will be used to evaluate a self-management program for
people with diabetes and cardiac disease that incorporates the use of simple remote-access communication
technologies. A sample size of 180 participants from Australia and Taiwan will be recruited and randomised in a
one-to-one ratio to receive either the intervention in addition to usual care (intervention) or usual care alone
(control). The intervention will consist of in-hospital education as well as follow up utilising personal telephone
calls and SMS reminders. Primary short term outcomes of interest include self-care behaviours and self-efficacy
assessed at baseline and four weeks.
Discussion: If the results of this investigation substantiate the feasibility and efficacy of the telephone and SMS
intervention for promoting self management among patients with diabetes and cardiac disease in Australia and
Taiwan, it will support the external validity of the intervention. It is anticipated that empirical data from this
investigation will provide valuable information to inform future international collaborations, while providing a platform
for further enhancements of the program, which has potential to benefit patients internationally.
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Cardiac disease and type 2 diabetes are global health
problems. In 2011, 17% of Australians (3.4 million) were
reported to have cardiovascular disease [1] and these pa-
tients often suffer other comorbidities including type 2
diabetes [2]. The presence of both diabetes and a cardiac
condition increases a patients’ likelihood of hospital re-
admission [1]. The prevalence of these conditions is pre-
dicted to increase, which will impact both health care
expenditure and the health-related quality of life of
people who develop these conditions [1,3,4].
With Westernisation, cardiac disease and diabetes have
dramatically increased in Asian countries [5,6], with a simi-
lar prevalence of these diseases in Australia and in Taiwan
[7,8]. The prevalence, mortality rate and healthcare cost
of diabetes and cardiac disease have dramatically in-
creased in Taiwan. In 2010, the prevalence of diabetes was
9.2% (2.11 million) in Taiwanese population [9]. Type 2
diabetes accounted for 11.5% of the total healthcare ex-
penditure in Taiwan with most expenditure related to
diabetic complications [10]. Cardiac disease was ranked as
the second leading cause of death and diabetes was the
fifth in 2010 [11].
With both countries experiencing the increasing eco-
nomic and human consequences of these diseases in the
context of finite healthcare and financial resources, in-
novative methods of health service delivery are required.
A number of studies have demonstrated the effectiveness
of self-management programs within the context of cardiac
rehabilitation to assist patients to modify their lifestyle and
achieve better health outcomes [12,13]. Self-management
incorporating telephone and text-messages focussed on
singular chronic diseases have also been associated with
health benefits [4,14]. However, limited literature is avail-
able on self-management programs for patients with both
cardiac disease and diabetes.
Some our previous work has investigated the use of
home visits and telephone follow-up among cardiac pa-
tients with diabetes following an acute coronary care
hospital admission to promote subsequent self manage-
ment among this clinical population [15]. This pilot
randomised trial with 20 participants demonstrated an
increase in knowledge of cardiac and diabetes conditions
among patients in the intervention group and supported
the feasibility of this style of intervention [15]. The in-
creasing popularity of Short-Message-Service (SMS) of-
fers a useful addition to conventional telephone calls as
a modality for communication between health profes-
sional and patients [16]. In a subsequent study, we inves-
tigated incorporating user-friendly and inexpensive SMS
in addition to telephone calls to promote increased cardiac
and diabetes condition knowledge among English-speaking
Australians [17]. This cardiac-diabetes self-management
program with telephone and SMS follow-up (T-CDSMP)increased knowledge of diabetes and cardiac conditions
among patients in the intervention group [17].
Increasing condition knowledge is only one step
toward changing self-management behaviours among
patients with chronic conditions [18]. In addition to
increasing knowledge, our T-CDSMP is intended to
improve self-efficacy, self-management behaviours and
subsequently health-related quality of life among pa-
tients with diabetes and cardiac conditions, as well as
potentially reduce their risk of acute health events re-
quiring hospital admission. It is envisaged that this T-
CDSMP will not only be useful among English speaking
patients, but also among patients from other cultural
backgrounds where diabetes and cardiac conditions are
similarly problematic.
Aims
The primary aim of this investigation is to assess the
short term effectiveness of the T-CDSMP on self-efficacy
and self-care behaviour among patients with diabetes
who also have cardiac disease in Australia and Taiwan.
The secondary aim is to investigate the effect of the T-
CDSMP on change in condition knowledge and health-
related quality of life among these patients.
Hypothesis
The hypothesis for the study is that the intervention
group participants receiving the Cardiac-Diabetes Self-
Management Program incorporating Telephone and
Text-message reminders will increase their levels of self-




A two group, randomised block design with blinded out-
come assessment will be used to address the heterogen-
eity of participants from differing cultural contexts [19].
Country location (Australia or Taiwan) will be the blocking
variable and will ensure equal representation of patients
from each country. This trial will include a follow-up of
1 month, to evaluate the short term outcomes of self-
management practice and self-efficacy, as well as condition
knowledge and health-related quality of life. An overview
of the study design is provided in Figure 1.
Participants
A total of 180 patients from Australia (n=90) and Taiwan
(n=90) will be recruited. Patients from each country will be
randomly allocated aiming for 45 patients in control and
intervention groups within each location block (Figure 1).
Patients will be eligible for inclusion if they have been
admitted to participating coronary care units (within
Australia or Taiwan) with a diagnosis of acute coronary
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Figure 1 Study design: overview of data collection.
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than 1 year, are aged over 18 years old, have access to a
telephone / device that can receive SMS, are able to read
and converse in English or Chinese, and are considered
medically stable by their treating clinical team. Patients
will be excluded from participation in the study if they
are critically ill, unconscious, or are on respiratory ven-
tilator support. Additionally, patients who have an in-
patient stay greater than 14 days will be excluded from
a per-protocol analysis (as these patients will not be at
home to receive the first telephone call at the sched-
uled time); these patients will still be included in the
intention-to-treat analysis.
Eligible patients will be approached by a trained Re-
search Assistant (RA) to obtain their individual informed
consent prior to baseline data collection. Patients will be
randomised to either the control or intervention groups
according to the randomisation process outlined below
(Figure 1). Participants in the control group will receive
the usual hospital educational program comprising rou-
tine cardiac education and referral to diabetes educator
if necessary. Participants in the intervention group will
receive the usual hospital educational program as wellas the cardiac-diabetes self-management program in-
corporating telephone and text-message reminders
(T-CDSMP).
Randomisation
An independent statistician, not otherwise involved in
the study, will use computerised random number gener-
ation to allocate each potential participant identification
number to the intervention or control group (in a one to
one ratio for both locations). The allocation sequence
will only be known to this person who will conceal the
allocation for each participant identification number in
corresponding sequentially numbered opaque envelopes.
The numbered envelopes will be stored in a locked cabi-
net only accessible to a randomisation gatekeeper at
each of the participating locations. Participants will be
assigned a participant identification number in order of
recruitment. After a patient has been assigned a partici-
pant identification number and completed baseline as-
sessments, the member of the research team responsible
for coordinating the interventions at the site will receive
the allocation envelope from the local randomisation
gatekeeper. They will then open the envelope to reveal
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be directly told of their group allocation (in terms of
intervention or control). Instead, control group partici-
pants will continue to receive their usual care, and the
intervention group participants will receive the T-CDSMP
in addition to their usual care.
Intervention
Participants who are allocated to the control group will
receive the usual educational program while they are in
hospital. This study involves multiple sites in different
countries with differing healthcare systems; therefore,
the delivery of any usual care education program will be
centre-oriented to represent usual care at that facility.
Data pertaining to usual care in the different centres will
be collected to inform conclusions that may be drawn
from location specific sub-group analyses. Patients who
are allocated to the intervention group will receive the
usual educational programs as well as the T-CDSMP.
Research staff will be trained and supervised by the re-
search team to deliver the intervention. The T-CDSMP,
developed by the research team previously [17] is based
on the self-efficacy principle of Bandura’s Social Cog-
nitive Theory [20]. The program consists of two face-
to-face sessions, one telephone call (1 week post discharge)
and two SMS (1 week post telephone follow-up). The
program will be delivered by a research nurse (Figure 1).
Strategies used will include utilising a range of infor-
mation sources (mastery, vicarious experience, verbal
persuasion and self-appraisal) [20] to assist patients
in developing problem-solving approaches as necessary
and the basic skills of monitoring their diet, physical ac-
tivity, medications and blood glucose levels. Relevant
case studies using case study booklets which include real
stories of common scenarios from patients in Australian
and Taiwanese hospitals will be discussed and patients
taught other aspects of self-care such as how to recog-
nise signs and symptoms requiring immediate medical
attention.
Data collection
There are two primary and two secondary outcomes to
be measured for this study. The two primary outcomes
include self-management practice and self-efficacy. The
two secondary outcomes include health-related quality
of life and knowledge of the conditions. Data will be col-
lected in two episodes: at baseline (Time 1) which is after
the patients’ physical condition has stabilised and they
have given their consent, but before being randomised;
and one month after being discharged to home (Time 2).
At baseline data collection, demographic data and out-
come variables will be collected. At the second data col-
lection, primary and secondary outcomes measures will
be completed.Measures
Questionnaires (in English and Chinese versions) will be
used for collecting data at Time 1 and Time 2. Self man-
agement behaviour will assessed using the Summary of
Diabetes Self-Care Activities [21,22]. Self-efficacy will be
assessed using the Diabetes Management Self-Efficacy
Scale (Australian-English version and Chinese version)
[23,24]. Knowledge will be examined with a knowledge
of condition questionnaire [25]. Health-related quality
of life will be evaluated using the brief version of the
World Health Organisation Quality of Life questionnaire
(WHOQoL-BREF) [26,27].
Data analysis
Prior to the commencement of data analysis, group
(intervention or control) and location (Australia or
Taiwan) variables will be re-coded to a pair of numbers
between one and ten to which the data analyst will be
blinded. In this way, the data analyst will be blinded to
the group and location data code. Data analysis will be
conducted with an intention-to-treat principle. Then the
analysis will be repeated (for a per-protocol analysis) ex-
cluding patients with a length of stay greater than 14
days. This planned per-protocol analysis will permit an
examination of the robustness of study findings to the
delayed commencement of the telephone follow-up
component of the intervention among the sample (due
to lengths of stay longer than two weeks). While the in-
vestigators anticipate that the intention-to-treat and
per-protocol analyses will return the same pattern of
findings (not many participants are likely to have an
acute length of stay of greater than 14-days), the per-
protocol analysis will act as a sensitivity analysis with
pragmatic implications for the subsequent potential trans-
lation of the intervention into health services. If the level
of effectiveness of the intervention among the study sam-
ple were influenced by the exclusion or (inclusion) of pa-
tients whose follow-up telephone call was delayed due
to a longer length of stay, this would have implications
for potential efforts to identify patients likely to have a
longer length of stay or potential future intervention
delivery modifications.
Baseline demographic information of participants in
each location will be outlined for the intervention and
control groups using descriptive statistics. Conventional
tests of hypothesis (e.g. t-tests, Mann–Whitney U, Chi-
squared) will be used where indicated to examine poten-
tial differences at baseline that may require adjustments
to be made when examining the influence of group
(intervention or control) and location (Australia versus
Taiwan) on primary and secondary outcomes. Analysis
of variance / covariance will be used to examine the
main effects of group (intervention or control) and loca-
tion (Australia or Taiwan) as well as potential interaction
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ary outcomes. If indicated, conventional tests of hypoth-
esis will be used to examine differences between primary
and secondary outcomes across group and location.
Where assumptions for parametric analyses have not
been met, data will be transformed (where possible) or
non-parametric alternatives will be used to make these
comparisons. Data analysis will be undertaken using the
Statistical Packages for the Social Sciences (SPSS) and
STATA IC with a preset alpha of 0.05.
Sample size
Sample size calculations were conducted based on con-
servative estimates to detect a between groups difference
in primary outcomes at either location. For example, a
location sample size of 90 has >80% power to detect a
between groups mean difference of 11 points in the
Summary of Diabetes Self-Care Activities outcome (scale
range is 0 to 57) [21] and 10 points on the Diabetes
Management Self-Efficacy Scale (scale range typically 62
to 200) [23], assuming standard deviations of 15.8 and
14.4 respectively, an alpha of 0.05, and exclusions due to
long length of stay (or loss to follow up) of up to 28% of
datasets at each site. Mean differences (and standard de-
viations) of this magnitude, and this potential attrition
rate are more conservative than a prior intervention trial
using these same outcome measures (but evaluating a
clinic only based intervention) and our own pilot investi-
gations [15,28]. Given the repeated measures nature of
the data, and dual locations, this investigation will there-
fore have greater than 90% power to detect simple main
effects of intervention (versus control) for the entire
sample, and differences between location blocks (90 par-
ticipants in each location).
Ethical considerations
Ethical approvals have been sought and granted by
all participating hospitals and universities in Australia
and Taiwan, specifically: Royal Brisbane and Women’s
Hospital Human Research Ethics Committee: Ref No:
HREC/10/QRBW479, Mater Health Services Human
Research Ethics Committee: Ref No:1662A, Queensland
University of Technology Human Research Ethics Com-
mittee: Approval No: 1100000297, Buddhist Tzu Chi
General Hospital Institutional Review Board: IRB099-112.
Main ethics considerations included: 1) obtaining patients’
informed consent, highlighting that they are volunteers
and could withdraw at any time; and 2) maintaining pa-
tients’ confidentiality through ensuring all information
kept is non-identifiable. Data will be stored on a secure
network, protected by password, and only accessed by
researchers involved in this study. This investigation
will be carried out in compliance with the Helsinki
Declaration. This study protocol has been registered withthe Australia and New Zealand Clinical Trials Registry
(ACTRN12611001196932).
Discussion
This paper has outlined a protocol for undertaking a study
investigating a telephone and SMS delivered cardiac-
diabetes self-management program for cardiac patients
with diabetes, across two cultural contexts, measuring the
outcomes of self-management behaviour, self-efficacy as
well as condition knowledge and health-related quality of
life. This international collaborative project aims to build
on our previous T-CDSMP piloting to fulfil the needs of
patients with dual cardiac and diabetes diagnoses from
English and non-English speaking backgrounds. Our pre-
vious studies have provided some evidence of benefit of
the T-CDSMP, particularly in the area of improving pa-
tient’s knowledge of their conditions. However the ad-
vancement of this program of research through this
investigation will provide valuable empirical data to sup-
port or refute the expanded use of this program by a wider
population by providing information on the impact of the
program on patients from differing cultures. The potential
of the program to be translated and utilised in other coun-
tries will be identified through this study, with findings
providing valuable information and direction for future re-
search to benefit patients with co-morbidities of type 2
diabetes and cardiac disease. This investigation will also
form the foundation of future investigations into the
medium term impacts of this intervention on health re-
source usage and clinical outcomes, such as hospital re-
admission rates.
Clinical implications
This study will provide clinical trial data to inform self-
management programs selection for patients with car-
diac disease and diabetes in different cultural contexts.
It will also provide important information for nursing
and medical staff seeking to incorporate remote-access
communication technologies (telephone and SMS) into
self-management programs for patients with dual con-
ditions of cardiac disease and diabetes. These patients
with dual diagnoses have poorer health outcomes and
complex management requirements. Current models of
health care tend to compartmentalise management with
increasingly specialised care for different diseases. How-
ever, this is in direct contrast to the reverse trend of
chronic disease with increasing numbers of aging pa-
tients with multiple comorbidities. Our program seeks
to allow the patient to take a more active role in the
process of harmonising care across different special-
ties. Furthermore, whilst our program is focussed on
diabetes and cardiac disease, it may nonetheless provide
a model of care which may be transferrable to other
chronic diseases.
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There were challenges experienced when planning this
study protocol, including understanding the variations in
research processes, healthcare personnel knowledge and
skill across two countries. Strategies for ensuring data
collection procedures and intervention delivery will be
consistent and rigorous, required substantial time, sig-
nificant planning and clear communication strategies
amongst all research team members. A limitation of this
investigation is that it does not have scope to assess
medium term impacts on health care resource usage and
clinical outcomes, such as hospital readmission rates.
Conclusion
This proposed international, collaborative, intervention
study across two differing cultures using a randomised
controlled trial design (with country as a blocking variable),
will provide valuable information on cultural variations
that may need to be addressed to improve delivery of self-
management programs that incorporate telephone and text
messaging follow-up. Investigating whether this program
incorporating inexpensive, user friendly remote-access
communication technologies to meet the needs of diabetes
patients with acute coronary syndrome across two diverse
countries will also provide insights into the potential bene-
fit of expanding these techniques for use in other similar
programs globally.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
C-JW contributed to idea conception, study design, coordination of study
preparation (Australia), data analysis plan, principal drafting of this protocol,
as well as appraisal, editing and drafting of protocol revisions. H-CS
contributed to study design, study preparation (Taiwan) and protocol
appraisal. AC, JA, KK, and MC contributed to study design and appraisal of
the protocol. SMM contributed to study design, appraisal of the protocol,
drafting of revisions and data analysis plan. All authors read and approved
the final manuscript.
Acknowledgements
This study is funded by the Institute of Health and Biomedical Innovation
Human Health and Wellbeing Domain Collaborative Research Development
Grant Scheme, Queensland University of Technology. SMM is supported by a
National Health and Medical Research Council (Australia) Clinical Research
Fellowship. The authors would also like to express special thanks to clinical
collaborators: Department of Cardiology, Royal Brisbane and Women’s
Hospital, Brisbane, Australia; Department of Cardiology, Mater Health
Services, South Brisbane, Australia; Associate Professor Shu-Chuan Chang
(Director, Department of Nursing, Tzu Chi Hospital Hualien, Taiwan).
Author details
1School of Nursing, Faculty of Health, Queensland University of Technology,
Victoria Park Road, Kelvin Grove QLD 4059, Australia. 2Institute of Health and
Biomedical Innovation Queensland University of Technology, Victoria Park
Road, Kelvin Grove QLD 4059, Australia. 3Department of Nursing, Tzu Chi
College of Technology; Institute of Medical Sciences, Tzu Chi University,
Hualien, Taiwan. 4Taiwanese Centre for Evidence-based Health Care, Hualien,
Taiwan. 5Mater Medical Research Institute, Mater Health Services, Brisbane,
Australia. 6School of Medicine, University of Queensland, Herston QLD 4029,
Australia. 7Department of Cardiology, Royal Brisbane and Women’s Hospital,
Butterfield Street, Brisbane QLD 4029, Australia. 8Mater Health Services,Raymond Terrace, South Brisbane QLD 4101, Australia. 9School of Nursing,
Midwifery and Paramedicine, Australian Catholic University, Banyo QLD 4014,
Australia. 10Centre for Functioning and Health Research, Metro South Health,
Corner of Ipswich Road and Cornwall Street, Woolloongabba QLD 4102,
Australia. 11School of Public Health and Social Work, Faculty of Health,
Queensland University of Technology, Victoria Park Road, Kelvin Grove QLD
4059, Australia.
Received: 27 July 2012 Accepted: 7 October 2013
Published: 9 October 2013References
1. Australian Institute of Health Welfare (AIHW): Cardiovascular health. Available
at: http://www.aihw.gov.au/cardiovascular-health/; 2011.
2. Caughey GE, Vitry AI, Gilbert AL, Roughead EE: Prevalence of comorbidity
of chronic diseases in Australia. BMC Public Health 2008, 8(221). 10.1186/
1471-2458-8-221. BioMed Central Open Access On line publication Available
at: http://www.biomedcentral.com/content/pdf/1471-2458-8-221.pdf.
3. Goss J: Projection of Australian health care expenditure by disease, 2003–2033.
Cat No. HWF 43. Canberra: Australian Institute of Health and Welfare; 2008.
4. McPhail S, Schippers M: An evolving perspective on physical activity
counselling by medical professionals. Bmc Family Practice 2012, 13(1):31.
5. Hossain P, Kawar B, Nahas MEI: Obesity and diabetes in the developing
world – A growing challenge. New Eng J Med 2007, 356:213–215.
6. Bauman A, Bull F, Chey T, Craig CL, Ainsworth BE, Sallis J, Bowles HR,
Hagstromer M, Sjostrom M, Pratt M, IPS Group: The international prevalence
study on physical activity: results from 20 countries. Int J Behav Nutr Phy 2009,
6(21): . BioMed Central Open Access On line publication. Available at: http://
www.biomedcentral.com/content/pdf/1479-5868-6-21.pdf.
7. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pr 2010, 87:4–14.
8. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M,
Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T: Cardiovascular
disease and risk factors in Asia: a selected review. Circulation 2008,
118:2702–2709.
9. Department of Health: Health and Vital Statistics. Taipei, Taiwan: Department
of Health; 2010. Retrieved from: http://www.mohw.gov.tw/EN/Ministry/
Statistic.aspx?f_list_no=474&fod_list_no=3506.
10. Tseng CH: Prevalence and risk factor of peripheral arterial obstructive
disease in Taiwanese type 2 diabetes patients. Angiology 2003, 54:331–338.
11. Department of Health: Health and Vital Statistics Vol. 1 Leading cause statistics.
Taipei, Taiwan: Department of Health; 2010. Retrieved from: http://www.mohw.
gov.tw/EN/Ministry/Statistic.aspx?f_list_no=474&fod_list_no=3506.
12. Neubeck L, Freedman SB, Clark AM, Briffa T, Bauman A, Redfern J:
Participating in cardiac rehabilitation: a systematic review and
meta-synthesis of qualitative data. Euro J Prev Card 2012, 19(3):494–503.
13. Heinrich E, Schaper NC, de Vries NK: Self-management interventions for
type 2 diabetes: a systematic review. Euro diabetes Nur 2010, 7(2):71–76.
http://onlinelibrary.wiley.com/doi/10.1002/edn.160/full.
14. Kim H: A randomized controlled trial of a nurse short-message service by
cellular phone for people with diabetes. Int J Nur Stud 2007, 44(5):687–692.
15. Wu C-J (J), Chang AM, McDowell J: Innovative self-management
programme for diabetics following coronary care unit admission. Int Nur
Rev 2009, 56:396–399.
16. Wei J, Hollin I, Kachnowski S: A review of the use of mobile phone text
messaging in clinical and healthy behaviour interventions. J Telemed
Telecare 2011, 17:41–48. doi:10.1258/jtt.2010.100322.
17. Wu C-J (J), Chang AM, Courtney M, Ramis M-A: Using user-friendly
telecommunications to improve cardiac and diabetes self-management
programme: a pilot study. J Eval Clin Pract 2011, 18(3):695–697.
18. Noar SM, Zimmerman RS: Health behaviour theory and cumulative
knowledge regarding health behaviours: are we moving in the right
direction. Health Edu Res 2005, 20(3):275–290.
19. Portney LG, Watkins MP: Foundations of Clinical Research: Applications to
Practice. New Jersey: Pearson/Prentice Hall; 2009.
20. Bandura A: Swimming against the mainstream: the early years from chilly
tributary to transformative mainstream. Behav Res Ther 2004, 42:613–630.
21. Toobert DJ, Hampson SE, Glasgow RE: The summary of diabetes self-care
activities measure: results from 7 studies and a revised scale.
Diabetes Care 2000, 23:943–950.
Wu et al. BMC Health Services Research 2013, 13:402 Page 7 of 7
http://www.biomedcentral.com/1472-6963/13/40222. Xu Y, Savage C, Toobert D, Pan W, Whitmer K: Adaptation and testing of
instruments to measure diabetes self-management in people with type
2 diabetes in mainland China. J Transcul Nur 2008, 19(3):234–242.
23. McDowell J, Courtney M, Edwards H, Shortridge-Baggett L: Validation of
the Australian/English version of the diabetes management self-efficacy
scale. Int J Nur Pract 2005, 11:177–184.
24. Wu SF: Development and validation of the Chinese version of diabetes
management self-efficacy scale. Int J Nur Stud 2008, 45(4):534–542.
25. Persell SD, Keating NL, Landrum MB, Landon BE, Ayanian JZ, Borbas C,
Guadaqnoli E: Relationship of diabetes-specific knowledge to self-
management activities, ambulatory preventive care, and metabolic
outcomes. Prev Med 2004, 39(4):746–752.
26. Murphy B, Herrman H, Hawthorne G, Pinzone T, Evert H: Australian WHOQoL
instruments: User’s manual and interpretation guide. Melbourne, Australia:
Australian WHOQoL Field Study Centre; 2000.
27. Department of Medical Statistics and Epidemiology SYSU: Instruments for
quality of life assessment. In WHOQOL-BREF. Beijing: Chinese Standard
Publishing House; 1999.
28. Shi Q, Ostwald SK, Wang S: Improving glycaemic control self-efficacy and
glycaemic control behaviour in Chinese patients with Type 2 diabetes
mellitus: randomised controlled trial. J Clin Nur 2010, 19(3–4):398–404.
doi:10.1186/1472-6963-13-402
Cite this article as: Wu et al.: Protocol for a randomised blocked design
study using telephone and text-messaging to support cardiac patients
with diabetes: a cross cultural international collaborative project. BMC
Health Services Research 2013 13:402.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
